PhD at The Max Planck Institute of Molecular Biomedicine – Bourses de recherche Allemagne 2019
The Max Planck Institute of Molecular Biomedicine - CiM-IMPRS PhD Fellowships in Germany, 2019 is offered for PhD degree in the field of Life and Natural Sciences. The deadline for the sending your application is 31 Mar 2019. This scholarship is provided by The Max Planck Institute for Molecular Biomedicine and the value of this scholarship is Partial Funding, €1400-€1468 per month. . This scholarship is open for: Open to all nationalities.
En quoi consiste le PhD at The Max Planck Institute of Molecular Biomedicine – Bourses de recherche Allemagne 2019 ?
Type de bourse
Bourse de Recherche
Pays
Allemagne
Date début de candidature
30/03/2019
Date limite de dépot de dossier
31/03/2019
Niveau d'étude
Doctorat
Connectez-vous
Inscrivez-vous gratuitement
Informations sur PhD at The Max Planck Institute of Molecular Biomedicine – Bourses de recherche Allemagne 2019 ?
- Degree: PhD
- Deadline: 31 Mar 2019
- Scholarship value: Partial Funding, €1400-€1468 per month.
- The candidates applying should have a Master's degree or equivalent in life or natural sciences such as biology, biochemistry, biotechnology, physics, chemistry, pharmacy or related fields, in mathematics or computer sciences.
- The candidates with a state examination in pharmacy are eligible to be admitted to work on pharmaceutical/chemical projects.
- The Master's or diploma or state examination must not be older than 4 years.
- Applicants who did not receive their degree yet can still...
Comment postuler à PhD at The Max Planck Institute of Molecular Biomedicine – Bourses de recherche Allemagne 2019 ?
Autres bourses qui pourraient vous intéresser
Brief description of the program : « Master at University of York Management School – Bourse d’études UK 2024 » The University of York is one of the success sto...
Brief description of the program : « Undergraduate, Masters at University of Bologna – Bourse d’études Italie 2024 » Level of Study: Undergraduate, Masters...
